Obagi Files 8k Officially Removing Poison Pill, Clears Way For Acquisition - Stock Market News & Financial Analysis -BoardProspects

Obagi Files 8k Officially Removing Poison Pill, Clears Way For Acquisition

Stock Market News & Financial Analysis Jul 11 2012 BoardNews

On February 10, 2012, Voce sent a letter to the Obagi Board of Directors criticizing the Board's adoption of a poison pill and demanding immediate action to address the company's corporate governance failures. Voce's letter in part stated that it believed ...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Have the Swiss Gone Cuckoo? also categorized in BoardNews
- Why Should We Care About Corporate Interlocks? also categorized in BoardNews
- Netflix: Icahn Says Poison Pill 'Poor Corporate Governance' also categorized in BoardNews
- Ultrapetrol: A Case Study On Questionable Corporate Governance also published in Stock Market News & Financial Analysis
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews
- Germany's Corporate Governance Problem also categorized in BoardNews
- 20 Taiwan Businesspeople To Watch -- James Kuo, Austin Liu and Andy Lu also categorized in BoardNews
- Six Years Later, The Problem at HP is Still the Board also categorized in BoardNews
- The Other Duty of Corporate Governance also categorized in BoardNews
- Boeing CFO Joins JPMorgan Board also mentions Board of Directors

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned
- Board of Directors